Heritage Wealth Management (Arizona)’s Regeneron Pharmaceuticals REGN Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3K	Buy	+5	New	+$3.1K	﹤0.01%	788

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s REGN Position: Q3 2021 in Review

Heritage Wealth Management (Arizona) opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2021: 5 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings.

1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

Heritage Wealth Management (Arizona) held 5 shares of Regeneron Pharmaceuticals worth $3K as of Q3 2021.
Regeneron Pharmaceuticals was a new Heritage Wealth Management (Arizona) position in Q3 2021.
Regeneron Pharmaceuticals made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q3 2021, its #788 holding.
1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q3 2021, filed 10 Nov 2021.